Different Aspects and Etiologies of Gastointestinal Bleeding in Patients With Systemic Lupus Erythematosus

Launched by ASSIUT UNIVERSITY · Oct 12, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at how systemic lupus erythematosus (SLE), a condition that affects the immune system, might lead to gastrointestinal bleeding, which is bleeding in the digestive tract. Researchers want to understand the different reasons why this bleeding occurs in patients with SLE. This study is not yet recruiting participants, but when it begins, it will focus on adults aged 18 and older, regardless of gender, who have been diagnosed with systemic lupus erythematosus.

To participate, individuals must be over 18 and have SLE, but those who have other conditions that can also cause gastrointestinal bleeding, like ulcerative colitis or Crohn’s disease, will not be eligible. Participants in this trial can expect to contribute to important research that may help improve understanding and treatment of gastrointestinal issues in people with SLE. This study aims to shed light on a significant health concern, ultimately benefiting patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • - Patient more than 18 years old classified as systemic lupus erythematosus Both sex
• Exclusion Criteria:
• • Patients with other clinical conditions that causes gastrointestinal bleeding as ulcerative colitis \& chrons